Recurrent Ovarian Carcinoma Recruiting Phase 1 Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0030000 (Recurrent Ovarian Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs